Literature DB >> 12782813

Immunohistochemical characterization of the epidermoid formation in the middle ear.

Jianning Liang1, Leslie Michaels, Anthony Wright.   

Abstract

OBJECTIVE: To study the incidence, size, and origin of epidermoid formations after accurately characterizing them by cytokeratin immunohistochemical analysis. STUDY
DESIGN: A strategy of screening sections for possible epidermoid formations in the entire eardrum area in paraffin-embedded, serially sectioned developing temporal bones was used. Unstained adjacent sections were subjected to immunohistochemical staining, to provide accurately identified epidermoid formations for a study of their appearance and size in relation to age.
METHODS: The immunohistochemical expression patterns for epidermoid cytokeratins of several antibodies at different gestational ages were determined. Then, epithelial structures suspected as epidermoid formations were characterized as epidermoid with age-appropriate antibodies in 36 paraffin-embedded temporal bones from 19 cases with an age range of 6 gestational weeks to 15 months postpartum using a novel method of antigen retrieval by heating sections in a 70 degrees C water bath.
RESULTS: Each of 22 temporal bones ranging in age from 16 weeks gestation to 8 months postpartum contained one or more, often numerous, epidermoid formations. Sizes of epidermoid formations increased significantly with increasing age. The formations were found anywhere in the annular lateral wall region of middle ear, but the majority were in the anterosuperior region. A further study of the interface between annular external canal epidermis and middle ear epithelium in a larger group suggested that epidermoid formations arise at approximately 16 gestational weeks from the external canal epidermis.
CONCLUSION: The findings indicate that epidermoid tissue in the middle ear normally originates from external canal epidermis at approximately the 16th gestational week and grows before disappearing.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12782813     DOI: 10.1097/00005537-200306000-00017

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  6 in total

1.  Cytokeratin expression pattern in congenital and acquired pediatric cholesteatoma.

Authors:  Ewa Olszewska; Jürgen Lautermann; Can Koc; Matthias Schwaab; Stefan Dazert; Henning Hildmann; Holger Sudhoff
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-03-08       Impact factor: 2.503

2.  Middle ear congenital cholesteatoma: systematic review, meta-analysis and insights on its pathogenesis.

Authors:  Nelson Gilberto; Sara Custódio; Tiago Colaço; Ricardo Santos; Pedro Sousa; Pedro Escada
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-01-18       Impact factor: 2.503

3.  Laser-assisted cholesteatoma surgery: technical aspects, in vitro implementation and challenge of selective cell destruction.

Authors:  Philipp P Caffier; Ulrike Marzahn; Andrea Franke; Holger Sudhoff; Sergije Jovanovic; Andreas Haisch; Benedikt Sedlmaier
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-06       Impact factor: 2.503

4.  Congenital cholesteatoma localized to the mastoid cavity and presenting as a mastoid abscess.

Authors:  Salim M Sloma Tabook; Hazem M Abdel Tawab; Naveen Kumar Gopal
Journal:  Case Rep Otolaryngol       Date:  2015-04-15

5.  Congenital cholesteatoma localized to the tip of the mastoid bone: a case report and possible etiology.

Authors:  Seok Min Hong; Jun Ho Lee; Chan Hum Park; Hyung-Jong Kim
Journal:  Korean J Audiol       Date:  2014-09-16

6.  Growth of cholesteatoma by implantation of epithelial tissue along the femoral bone of rats.

Authors:  Sandra Lira Bastos de Magalhaes; Olga Maria Rojas Reforme; Raquel Liriano Guzmán; Yotaka Fukuda; Flávia Barbosa
Journal:  Braz J Otorhinolaryngol       Date:  2005-08-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.